Madelaine Lott, NP

NPI: 1871935908
Total Payments
$25.18
2021 Payments
$25.18
Companies
1
Transactions
2
Medicare Patients
859
Medicare Billing
$39,732

Payment Breakdown by Category

Food & Beverage$25.18 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $25.18 2 100.0%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $25.18 2 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2021 $25.18 2 Genentech USA, Inc. ($25.18)

All Payment Transactions

2 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/20/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $15.12 General
Category: Virology & Specialty Care
01/21/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $10.06 General
Category: Virology & Specialty Care

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 194 421 $14,335 $8,629
2022 6 154 188 $14,155 $7,164
2021 12 325 367 $23,291 $14,659
2020 5 186 227 $18,875 $9,280
Total Patients
859
Total Services
1,203
Medicare Billing
$39,732
Procedure Codes
31

All Medicare Procedures & Services

31 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 51 63 $7,245 $4,201 58.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 20 20 $2,900 $2,089 72.0%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 23 23 $1,035 $796.26 76.9%
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc Office 2023 14 14 $1,400 $703.92 50.3%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 13 25 $375.00 $367.50 98.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 36 42 $840.00 $330.24 39.3%
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg Office 2023 12 34 $340.00 $121.79 35.8%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 25 200 $200.00 $19.58 9.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 62 71 $8,165 $4,029 49.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 25 25 $3,000 $1,285 42.8%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 27 27 $1,180 $940.79 79.7%
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc Office 2022 11 11 $1,100 $557.72 50.7%
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg Office 2022 14 37 $370.00 $196.55 53.1%
96372 Injection of drug or substance under skin or into muscle Office 2022 15 17 $340.00 $154.46 45.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 73 85 $9,775 $6,559 67.1%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 78 78 $9,360 $4,732 50.6%
87426 Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 22 24 $960.00 $847.92 88.3%
0031A Adm sarscov2 vac ad26 .5ml Office 2021 19 19 $845.00 $707.18 83.7%
0002A Adm sarscov2 30mcg/0.3ml 2nd Office 2021 15 15 $635.00 $558.30 87.9%
0001A Adm sarscov2 30mcg/0.3ml 1st Office 2021 12 12 $515.00 $446.64 86.7%
0013A Fee covid-19 vac 2 booster Office 2021 12 12 $480.00 $446.64 93.1%
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg Office 2021 15 34 $340.00 $195.31 57.4%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 19 19 $380.00 $164.78 43.4%
91300 Sarscov2 vac 30mcg/0.3ml im Office 2021 26 34 $0.34 $0.34 100.0%
91303 Sarscov2 vac ad26 .5ml im Office 2021 22 23 $0.23 $0.23 100.0%

About Madelaine Lott, NP

Madelaine Lott, NP is a Nurse Practitioner healthcare provider based in Gardendale, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1871935908.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Madelaine Lott, NP has received a total of $25.18 in payments from pharmaceutical and medical device companies, with $25.18 received in 2021. These payments were reported across 2 transactions from 1 company. The most common payment nature is "Food and Beverage" ($25.18).

As a Medicare-enrolled provider, Lott has provided services to 859 Medicare beneficiaries, totaling 1,203 services with total Medicare billing of $39,732. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Gardendale, AL
  • Active Since 07/17/2013
  • Last Updated 12/18/2014
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1871935908

Products in Payments

  • Xofluza (Drug) $25.18

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Gardendale